ST250 as a Therapeutic Option for Head & Neck Reconstruction
ConditionTonsillitis
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorAlaa Emara
About this trial
To assess the use of SupraThel 250 for mucosal reconstruction in the Head \& Neck region. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing
Eligibility criteria
Qualifiers
recurrent episodes of tonsillar infection
Disqualifiers
children
pregnant/ breastfeeding women
patients undergoing chemo / radiotherapy
Trial design
Treatments tested in this trial
- SupraTHEL 250
- Comparator
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Alaa Emara
Lead sponsor
Cairo University
Sponsor institution
Source ClinicalTrials.gov